The Venture Codex Logo

The Venture Codex

Plateau de Saclay Business Angels

11 Rue de la Boétie, PARIS, 75008, France

Overview

A network of business angels called Plateau de Saclay Business Angels (PSBA) focuses on creative start-up ventures.

Total investments
2
Lead investments
0
Investments · 12mo
1
Active investors
0

Sector focus

  • Banking
  • Finance
Visit website

Investment portfolio

  • Skydrone Robotics

    Participated · Equity · Feb 2026

    Skydrone Robotics is a La Rochelle–based drone manufacturer that has evolved over the past decade from a start-up into a small industrial SME focused on both civil and military applications. Its aircraft are tailored for logistics missions such as transporting supplies for armed forces and performing inspection work on electrical power lines. The company currently employs about 20 people—three-quarters of whom are engineers—and is hiring 10 additional staff to support expansion. Fresh capital will finance a new 2,000 m² plant capable of assembling several hundred drones per year, marking a shift from prototyping to scaled production. Management’s stated ambition is to become a leading player in the European civil-military drone market. Besides ramping manufacturing, funds will also bolster R&D and operational capacity to meet growing demand.

  • MSInsight

    Participated · Seed · Mar 2025

    MSInsight is a Paris-based startup developing diagnostic solutions to identify clinically relevant information in patients' DNA to predict treatment success, with a focus on detecting Microsatellite Instability (MSI). Its flagship product, MSIcare, is medical device software that integrates bioinformatics algorithms and AI models to interpret genomic data and improve detection of the MSI biomarker across different cancers. MSIcare has been clinically validated for diagnosing MSI from tumor tissue samples in various cancers. The company raised €1.6M in seed funding and intends to use the proceeds to finalize technological development, demonstrate performance across cancer types, and begin regulatory clinical validation for CE‑IVD marking. MSInsight is also actively working to extend its application to simple blood diagnostics to enable a less invasive and more accessible approach. Led by Arnaud Cutivet, PhD, president and co‑founder, MSInsight combines bioinformatics and AI to democratize MSI testing and optimize result interpretation for clinical workflows.

Team

No current team members are available.